abstract |
Polymorphic forms of the tyrosine kinase inhibitor OSI-906, the preparation, pharmaceutical compositions, and uses thereof; The invention includes methods for treating diseases such as cancer, including cancer mediated at least in part by IGF-1R and / or IR, with polymorphs and compositions; This summary is not limiting of the invention. |